Miriam Monge to Join Sartorius Stedim Biotech
News Aug 27, 2014
Sartorius Stedim Biotech (SSB) has announced the appointment of Miriam Monge as Director of Marketing for SSB’s Integrated Solutions unit. In this newly created position, Monge will focus on sharpening SSB’s profile as an integrated solution provider for the biopharmaceutical industry.
Miriam Monge brings in more than 20 years of experience in the biopharmaceutical manufacturing sector and served, most recently, as Vice President of Sales & Marketing at the consultancy Biopharm Services.
She is a committee member of the International Society for Pharmaceutical Engineering (ISPE) and one of the founders of the Global Disposable Community of Practice. Miriam Monge regularly authors articles for technical bioprocess journals, analyzing the impact of disposable technologies on biomanufacturing.
“With Miriam Monge, we have gained an internationally recognized expert from the biopharmaceutical industry who will help us further position Sartorius Stedim Biotech as a total solution provider for biopharma companies,” stated Reinhard Vogt, member of the SSB Board of Directors.
Vogt continued, “Whenever our customers start planning a new facility or process, SSB’s Integrated Solutions unit is an ideal partner for designing and implementing entire single-use or hybrid production processes.”
Researchers Develop New Method to Generate Human AntibodiesNews
Researchers hope their approach will help researchers rapidly generate therapeutic antibodies for the treatment of infectious diseases and other conditions such as cancer.READ MORE
Cow Antibodies Yield Important Clues For Developing A Broadly Effective AIDS VaccineNews
The unexpected animal model is providing clues for important questions at a moment when new energy has infused HIV vaccine research.READ MORE
Cell Recycling System Offers Therapeutic Entry Point for Rare Disease TreatmentNews
Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).READ MORE